Prostate Cancer Screening (PDQ®): Screening - Patient Information [NCI] - Risks of Prostate Cancer Screening
Screening tests have risks. Decisions about screening tests can be difficult. Not all screening tests are helpful and most have risks. Before having any screening test,you may want to discuss the test with your doctor. It is important to know the risks of the test and whether it has been proven to reduce the risk of dying from cancer. The risks of prostate screening include the following: ...
Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®): Complementary and alternative medicine - Patient Information [NCI] - Questions and Answers About Modified Citrus Pectin
What is modified citrus pectin?Pectin is a type of polysaccharide (a carbohydrate with many small sugar molecules that are chemically linked). Pectin is found in the cell walls of most plants and has gel-like qualities that are useful in making many types of food and medicine.Citrus pectin is found in the peel and pulp of citrus fruits such as oranges, grapefruit, lemons, and limes. Citrus pectin can be modified with high pH and heat to break its molecules into smaller pieces. Modified citrus pectin (also called MCP) can be digested and absorbed by the body. How is MCP administered or consumed? MCP may be taken by mouth in powder or capsule form. Have any preclinical (laboratory or animal) studies been conducted using MCP? A study in prostate cancer cells compared 3 different kinds of pectin: citrus pectin, PectaSol (a dietary supplement with MCP), and fractionated pectin powder. Prostate cancer cells treated with the pectin powder had more damage than those treated with citrus pectin
Prostate Cancer Prevention (PDQ®): Prevention - Patient Information [NCI] - Changes to This Summary (05 / 25 / 2012)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above. Changes were made to this summary tot match those made to the health professional version.
Prostate Cancer Prevention (PDQ®): Prevention - Health Professional Information [NCI] - nci_ncicdr0000062833-nci-header
This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.Prostate Cancer Prevention
Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®): Complementary and alternative medicine - Health Professional Information [NCI] - Green Tea
OverviewThis section contains the following key information:All tea originates from the Camellia sinensis (L.) Kuntze plant, and the methods by which the leaves are processed determine the type of tea produced. For green tea, the leaves are steamed and dried.Some research suggests that green tea may have a protective effect against cardiovascular disease and against various forms of cancer.Catechins are polyphenol compounds in tea that are associated with many of tea's proposed health benefits.Epigallocatechin gallate (EGCG), the most abundant catechin in tea, acts as an androgen antagonist and can suppress prostate cancer cell proliferation, suppress production of prostate-specific antigen (PSA) by prostate cancer cells, and increase prostate cancer cell death in vitro.Results from one in vitro study showed that prostate cancer cells were less susceptible to radiation -induced apoptosis when exposed to EGCG 30 minutes before radiation exposure.Oral
Prostate Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - Treatment Option Overview
There are different types of treatment for patients with prostate cancer. Different types of treatment are available for patients with prostate cancer. Some treatments are standard (the currently used treatment),and some are being tested in clinical trials. Before starting treatment,patients may want to think about taking part in a clinical trial. A treatment clinical trial is a research ...
Prostate Cancer Prevention (PDQ®): Prevention - Health Professional Information [NCI] - About This PDQ Summary
PURPOSE OF THIS SUMMARY This PDQ cancer information summary for health professionals provides comprehensive,peer-reviewed,evidence-based information about prostate cancer prevention. It is intended as a resource to inform and assist clinicians who care for cancer patients. It does not provide formal guidelines or recommendations for making health care decisions. REVIEWERS AND UPDATES This ...
Prostate Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] - Get More Information From NCI
National Cancer Institute for more cancer information.
Prostate Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] - Significance
Incidence and Mortality Prostate cancer is the most common cancer diagnosed in North American men,excluding skin cancers. It is estimated that in 2006,approximately 234,460 new cases and 27,350 prostate cancer-related deaths will occur in the United States.[ 1 ] Prostate cancer is now the third leading cause of cancer death in men,exceeded only by lung cancer and colorectal cancer. It ...
Prostate Cancer Prevention (PDQ®): Prevention - Health Professional Information [NCI] - Overview
Note: Separate PDQ summaries on Prostate Cancer Screening,Prostate Cancer Treatment,and Levels of Evidence for Cancer Screening and Prevention Studies are also available. Benefits From Finasteride and Dutasteride Chemoprevention Based on solid evidence,chemoprevention with finasteride and dutasteride reduces the incidence of prostate cancer,but the evidence is inadequate to determine whether ...